EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Evaluation of Postoperative Thromboembolic Events in Orthotopic Heart Transplant Patients Receiving 4-Factor Prothrombin Complex Concentrate Monotherapy Versus Combination Therapy With Very Low-Dose Recombinant Activated Factor VII: A Retrospective Cohort Study

Lauren Schwaner, Kristen Goodrich, Jamel Ortoleva, Aaron Sparks, Gregory Couper, Alberto Furzan

Journal of Cardiothoracic and Vascular Anesthesia · 2026-09 · 40 (9) · 2885-2891

DOI: 10.1053/j.jvca.2026.04.030 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026-09. Verfasst von Lauren Schwaner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Tufts Medical Center, Boston, MA. Hauptthemen laut MEDLINE: Factor VIIa, Blood Coagulation Factors, Thromboembolism, Postoperative Complications. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES To explore whether the addition of very low-dose recombinant activated factor VII (rFVIIa) to 4-factor prothrombin complex concentrate (4F-PCC) increases postoperative thromboembolic events in patients undergoing orthotopic heart transplantation (OHT) complicated by severe coagulopathy. DESIGN Single-center, retrospective cohort study. SETTING Tertiary academic medical center in Boston, Massachusetts. PARTICIPANTS Adults (aged ≥ 18 years) who underwent OHT between January 1 and December 31, 2023, and received 4F-PCC, with or without rFVIIa, for perioperative coagulopathy. INTERVENTIONS Patients received either combination therapy with 4F-PCC and very low-dose rFVIIa (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIaBlood Coagulation FactorsThromboembolismPostoperative ComplicationsHeart TransplantationHumansRetrospective StudiesFemaleRecombinant ProteinsMaleCohort StudiesMiddle AgedDrug Therapy, CombinationAdultDose-Response Relationship, Drug

Stichwörter der Autor:innen

heart transplantationhemostasisprothrombin complex concentraterecombinant activated factor VIIthrombosis

Substanzen

Factor VIIaprothrombin complex concentratesRecombinant ProteinsBlood Coagulation Factorsrecombinant FVIIa

Autor:innen und Institutionen

  • Department of Pharmacology, Tufts Medical Center, Boston, MA.
  • Department of Pharmacology, NYU Langone Health, New York, NY.
  • Department of Anesthesiology, Boston Medical Center, Boston, MA.
  • Department of Cardiac Surgery, Tufts Medical Center, Boston, MA.
  • Department of Anesthesiology, Tufts Medical Center, Boston, MA. Electronic address: ajfurzan@gmail.com.

Zitieren

APA

Schwaner, L., Goodrich, K., Ortoleva, J., Sparks, A., Couper, G., & Furzan, A. (2026). Evaluation of Postoperative Thromboembolic Events in Orthotopic Heart Transplant Patients Receiving 4-Factor Prothrombin Complex Concentrate Monotherapy Versus Combination Therapy With Very Low-Dose Recombinant Activated Factor VII: A Retrospective Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia, 40(9), 2885-2891. https://doi.org/10.1053/j.jvca.2026.04.030

Vancouver

Schwaner L, Goodrich K, Ortoleva J, Sparks A, Couper G, Furzan A. Evaluation of Postoperative Thromboembolic Events in Orthotopic Heart Transplant Patients Receiving 4-Factor Prothrombin Complex Concentrate Monotherapy Versus Combination Therapy With Very Low-Dose Recombinant Activated Factor VII: A Retrospective Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 2026;40(9):2885-2891. doi:10.1053/j.jvca.2026.04.030

BibTeX
@article{Schwaner2026,
  author = {Schwaner, Lauren and Goodrich, Kristen and Ortoleva, Jamel and Sparks, Aaron and Couper, Gregory and Furzan, Alberto},
  title = {Evaluation of Postoperative Thromboembolic Events in Orthotopic Heart Transplant Patients Receiving 4-Factor Prothrombin Complex Concentrate Monotherapy Versus Combination Therapy With Very Low-Dose Recombinant Activated Factor VII: A Retrospective Cohort Study},
  journal = {Journal of Cardiothoracic and Vascular Anesthesia},
  year = {2026},
  volume = {40},
  number = {9},
  pages = {2885--2891},
  doi = {10.1053/j.jvca.2026.04.030}
}
Kostenlos starten →